文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Immunotherapy in non-small cell lung cancer: advancements and challenges.

作者信息

Zhou Fei, Zhou Cai-Cun

机构信息

Department of Medical Oncology, Shanghai Pulmonary Hospital, Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai 200433, China.

出版信息

Chin Med J (Engl). 2021 Feb 16;134(10):1135-1137. doi: 10.1097/CM9.0000000000001338.

DOI:10.1097/CM9.0000000000001338
PMID:33595975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8143766/
Abstract
摘要

相似文献

[1]
Immunotherapy in non-small cell lung cancer: advancements and challenges.

Chin Med J (Engl). 2021-2-16

[2]
[Immunotherapy for non-small-cell lung cancer].

Rev Prat. 2021-12

[3]
Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm.

Eur Respir J. 2020-2-6

[4]
Clinical Approaches to Immunotherapy in Non-Small Cell Lung Cancer: Current and Future Perspectives.

Curr Mol Pharmacol. 2016

[5]
Immunotherapy in Non-Small-Cell Lung Cancer Patients With Performance Status 2: Clinical Decision Making With Scant Evidence.

J Clin Oncol. 2019-8-1

[6]
Immunologic strategies for the treatment of non-small cell lung cancer.

Surgery. 2002-1

[7]
Lung cancer: potential targets for immunotherapy.

Lancet Respir Med. 2013-8-23

[8]
Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy.

Immunotherapy. 2017-9

[9]
Emerging Therapies in Thoracic Malignancies-Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non-Small Cell Lung Cancer.

Surg Oncol Clin N Am. 2020-10

[10]
Immunotherapy alone or chemo-immunotherapy as front-line treatment for advanced non-small cell lung cancer.

Expert Opin Biol Ther. 2019-1-25

引用本文的文献

[1]
Delayed Separation of Kaplan-Meier Curves is Commonly Observed in Studies of Advanced/Metastatic Solid Tumors Treated with Anti-PD-(L)1 Therapy: Systematic Review and Meta-Analysis.

Target Oncol. 2025-1

[2]
Metformin is a potential therapeutic for COVID-19/LUAD by regulating glucose metabolism.

Sci Rep. 2024-5-30

[3]
Pyrotinib as a salvage treatment for patients with HER-2 positive advanced lung adenocarcinoma after the progression of afatinib treatment.

Clin Transl Oncol. 2024-12

[4]
Immune checkpoint inhibitors beyond first-line progression with prior immunotherapy in patients with advanced non-small cell lung cancer.

J Thorac Dis. 2023-4-28

[5]
Comparative efficacy of various CHIs combined with western medicine for non-small cell lung cancer: A bayesian network meta-analysis of randomized controlled trials.

Front Pharmacol. 2022-11-10

[6]
Prognostic Value of Immunotyping Combined with Targeted Therapy in Patients with Non-Small-Cell Lung Cancer and Establishment of Nomogram Model.

Comput Math Methods Med. 2022

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索